作者：李妍漫1，2 ，郑在勇3 ，姜清陆1，2 ，彭海军1，2 ，蒲俊2 ，胡厚祥1，2

单位：

1.637000四川省南充市，川北医学院附属医院院士工作站　2.637000四川省南充市， 川北医学院附属医院心内科　3.646000四川省泸州市，西南医科大学附属医院心内科

单位（英文）：

1.Academician Workstation, Affiliated Hospital of North Sichuan Medical College, Nanchong 637000, China 2.Department of Cardiology, Affiliated Hospital of North Sichuan Medical College, Nanchong 637000, China 3.Department of Cardiology, the Affiliated Hospital of Southwest Medical University, Luzhou 646000, China

关键词：

心力衰竭；热点；研究趋势；文献计量学

关键词（英文）：

Heart failure; Hotspot; Research trend; Bibliometrics

中图分类号：

R 541.62

DOI：

10.12114/j.issn.1008-5971.2024.00.019

基金项目：

四川省卫生健康委员会医学科技项目（21ZD004）

摘要：

目的　利用文献计量学方法分析2017—2023年全球心力衰竭研究热点及趋势。方法　检索Web of Science（WOS）核心合集中关于心力衰竭的文献，限定语种为英语，出版时间限定为2017-01-01至2023-10-31。 剔除重复文献后根据纳入与排除标准进行文献筛选，提取相关资料，之后采用WOS的分析功能、VOS viewer（版本 1.6.18）、CiteSpace（版本V6.2）进行数据处理与可视化分析。结果　共检索到49 056篇文献，最终纳入文献25 318 篇。2017—2022年，心力衰竭领域文献年发文量和年被引频次均逐年增多；心力衰竭领域文献总发文量排名前5位的 国家分别是美国（8 883篇）、中国（3 915篇）、意大利（2 409篇）、日本（2 268篇）、英国（2 099篇）。总连接 强度最强的国家是美国（10 260），其次是英国（6 437）和德国（6 397），中国的总连接强度排名第18（1 999）。 2017—2023年，心力衰竭领域文献总发文量排名前3位的机构分别为杜克大学（824篇）、哈佛大学医学院（778 篇）、格拉斯哥大学（622篇）；心力衰竭领域文献总发文量排名前3位的期刊分别为ESC Heart Failure（1 249篇）、 European Journal of Heart Failure（788篇）、Frontiers in Cardiovascular Medicine（594篇）。聚类分析结果显示，Q值为 0.814 2，S值为0.929 5。2017—2023年心力衰竭领域共被引文献聚类图谱分析结果显示，文献的热点关键词主要为沙 库巴曲缬沙坦、恩格列净、生物标志物、钠-葡萄糖协同转运蛋白2（SGLT-2）抑制剂、MitraClip等。结论　随着心力 衰竭患病率的增加和新的治疗困境的出现，心力衰竭正受到越来越多的关注。不同国家在心力衰竭领域的发展是不平 衡的，该领域的主要研究力量仍集中在欧美发达国家和亚洲的中国及日本。虽然我国在心力衰竭领域的发文量较多， 但仍需继续努力发表高质量文献及打造高影响力研究机构。心力衰竭的药物治疗、心力衰竭与糖尿病的关系、心力衰 竭的生物标志物、MitraClip等是近年心力衰竭领域研究的热点。

英文摘要：

Objective To analyze the global heart failure research hotspots and trends from 2017 to 2023 by bibliometrics. Methods Literature on heart failure was retrieved from the Web of Science (WOS) core collection, the limited language was English, and the publication time was from January 1st, 2017 to October 31st, 2023. After removing duplicate literature, literature screening was conducted based on inclusion and exclusion criteria, and relevant information was extracted. Then, WOS analysis function, VOS viewer (version 1.6.18) , and CiteSpace (version V6.2) were used for data processing and visualization analysis. Results A total of 49 056 articles were retrieved, and 25 318 articles were ultimately included. From 2017 to 2022, the annual publication volume and citation frequency of literature in the field of heart failure increased year by year; the top 5 countries in the total number of heart failure literature publications were the United States (8 883) , China (3 915) , Italy (2 409) , Japan (2 268) , and the United Kingdom (2 099) . The country with the strongest total connection strength was the United States (10 260) , followed by the United Kingdom (6 437) and Germany (6 397) , and China ranked 18th (1 999) in total connection strength. From 2017 to 2023, the top three institutions of total number of literature in the field of heart failure were Duke University (824 articles) , Harvard Medical School (778 articles) , and the University of Glasgow (622 articles) ; top 3 journals of total number of literature in the field of heart failure were ESC Heart Failure (1 249 articles) , European Journal of Heart Failure (788 articles) , and Frontiers in Cardiovascular Medicine (594 articles) . The results of cluster analysis showed that Q value was 0.814 2 and S value was 0.929 5. The clustering analysis results of co-cited literature in the field of heart failure from 2017 to 2023 showed that the hot keywords in the literature were mainly sacubitril/valsartan, entegliflozin, biomarkers, sodium-dependent glucose transporters 2 (SGLT-2) inhibitors, MitraClip, etc. Conclusion With the increasing incidence of heart failure and the emergence of new treatment challenges, heart failure is receiving more and more attention. The development of heart failure in different countries is uneven, and the main research force in this field is still concentrated in developed countries in Europe and America, as well as China and Japan in Asia. Although China has published a large number of articles in the field of heart failure, efforts still need to be made to publish high-quality literature and build a high-impact research institution. The drug treatment of heart failure, the relationship between heart failure and diabetes, the biomarkers of heart failure, and MitraClip are the hot spots in the field of heart failure research in recent years.

参考文献：